Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference44 articles.
1. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease;M Rizvi;Trends in molecular medicine,2008
2. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity;L Zhou;Thrombosis and haemostasis,1998
3. From atherosclerosis to acute coronary syndromes: the role of soluble CD40 ligand;D Tousoulis;Trends in cardiovascular medicine,2010
4. Regulation of reactive oxygen species generation in cell signaling;YS Bae;Molecules and cells,2011
5. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species;C Urbich;Circulation,2002
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of SIRT-1 as a Target for Treatment and Prevention of Diabetic Nephropathy: A Review;Current Molecular Pharmacology;2023-12
2. Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes;Clinical Journal of the American Society of Nephrology;2023-10-16
3. Pelargonidin alleviates acrolein-induced inflammation in human umbilical vein endothelial cells by reducing COX-2 expression through the NF-κB pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-20
4. p38 mitogen‐activated protein kinase: Functions and targeted therapy in diseases;MedComm – Oncology;2023-09
5. A comprehensive insight into the molecular and cellular mechanisms of action of resveratrol on complications of sepsis a systematic review;Phytotherapy Research;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3